Citations

Citations to this article as recorded by  

• Intermittent cold stimulation affects energy metabolism and improves stress resistance in broiler heart
  Tingting Li, Haidong Wei, Shijie Zhang, Xiaotao Liu, Lu Xing, Yuanyuan Liu, Rixin Gong, Jianhong Li
  Poultry Science.2024; 103(1): 103190.     CrossRef

Fibrates, peroxisome proliferator-activated receptor-α agonists, are potent lipid-modifying drugs. Their main effects are reduction of triglycerides and increase in high-density lipoprotein levels. Several randomized controlled trials have not demonstrated their benefits on cardiovascular risk reduction, especially as an “add on” to statin therapy. However, subsequent analyses by major clinical trials, meta-analyses, and real-world evidence have proposed their potential in specific patient populations with atherogenic dyslipidemia and metabolic syndrome. Here, we have reviewed and discussed the accumulated data on fibrates to understand their current status in cardiovascular risk management.

Citations

Citations to this article as recorded by  

• Associations of omega-3 fatty acids vs. fenofibrate with adverse cardiovascular outcomes in people with metabolic syndrome: propensity matched cohort study
  Nam Hoon Kim, Ji Yoon Kim, Jimi Choi, Sin Gon Kim
  European Heart Journal - Cardiovascular Pharmacotherapy.2024; 10(2): 118.     CrossRef
• Role of PPARα in inflammatory response of C2C12 myotubes
  Yuki Shimizu, Keiko Hamada, Tingting Guo, Chie Hasegawa, Yusuke Kuga, Katsushi Takeda, Takashi Yagi, Hiroyuki Koyama, Hiroshi Takagi, Daisuke Aotani, Hiromi Kataoka, Tomohiro Tanaka
  Biochemical and Biophysical Research Communications.2024; 694: 149413.     CrossRef
• Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
  John J. P. Kastelein, Andrew Hsieh, Mary R. Dicklin, Marc Ditmarsch, Michael H. Davidson
  Current Atherosclerosis Reports.2024; 26(2): 35.     CrossRef
• Metabolic Flexibility of the Heart: The Role of Fatty Acid Metabolism in Health, Heart Failure, and Cardiometabolic Diseases
  Virginia Actis Dato, Stephan Lange, Yoshitake Cho
  International Journal of Molecular Sciences.2024; 25(2): 1211.     CrossRef
• ApoB100 and Atherosclerosis: What’s New in the 21st Century?
  Dimitris Kounatidis, Natalia G. Vallianou, Aikaterini Poulaki, Angelos Evangelopoulos, Fotis Panagopoulos, Theodora Stratigou, Eleni Geladari, Irene Karampela, Maria Dalamaga
  Metabolites.2024; 14(2): 123.     CrossRef
• Follistatin-like 1 (FSTL1) levels as potential early biomarker of cardiovascular disease in a Mexican population
  N. Ponce-Ruíz, J. F. Herrera-Moreno, A. E. Rojas-García, B. S. Barrón-Vivanco, C. A. González-Arias, Y. Y. Bernal-Hernández, L. Ortega-Cervantes, J. Ponce-Gallegos, J. A. Hernández-Nolasco, I. M. Medina-Díaz
  Heart and Vessels.2024; 39(6): 563.     CrossRef
• Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
  Chaicharn Deerochanawong, Sin Gon Kim, Yu-Cheng Chang
  Diabetes & Metabolism Journal.2024; 48(2): 184.     CrossRef
• Coenzyme Q10 in atherosclerosis
  Minjun Liao, Xueke He, Yangyang Zhou, Weiqiang Peng, Xiao-Mei Zhao, Miao Jiang
  European Journal of Pharmacology.2024; 970: 176481.     CrossRef
• Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study
  Maria Rosaria Paravati, Anna Caterina Procopio, Maja Milanović, Giuseppe Guido Maria Scarlata, Nataša Milošević, Maja Ružić, Nataša Milić, Ludovico Abenavoli
  Nutrients.2024; 16(8): 1226.     CrossRef
• Therapeutic approach in the treatment of dyslipidemia: Novelties and challenges
  Katarina Lalić, Nataša Rajković, Ljiljana Popović, Sandra Singh-Lukač, Iva Rasulić, Ana Petakov, Milica Krstić, Marija Mitrović
  Galenika Medical Journal.2024; 3(9): 31.     CrossRef
• Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis
  Quankai Cheng, Jingjing Sun, Haicheng Zhong, Ziming Wang, Chang Liu, Sheng Zhou, Jie Deng
  Frontiers in Pharmacology.2024;[Epub]     CrossRef
• Expression of FAM159B in Humans, Rats, and Mice: A Cross-species Examination
  Anna-Sophia Liselott Beyer, Daniel Kaemmerer, Jörg Sänger, Amelie Lupp
  Journal of Histochemistry & Cytochemistry.2024; 72(7): 467.     CrossRef
• The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
  Dimitris Kounatidis, Nikolaos Tentolouris, Natalia G. Vallianou, Iordanis Mourouzis, Irene Karampela, Theodora Stratigou, Eleni Rebelos, Marina Kouveletsou, Vasileios Stamatopoulos, Eleni Tsaroucha, Maria Dalamaga
  Metabolites.2024; 14(7): 388.     CrossRef
• Fenofibrate’s impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study
  Sangmo Hong, Kyung-Soo Kim, Kyungdo Han, Cheol-Young Park
  Cardiovascular Diabetology.2024;[Epub]     CrossRef
• The role of DGAT1 and DGAT2 in tumor progression via fatty acid metabolism: A comprehensive review
  Leisheng Wang, Shiwei Xu, Mengzhen Zhou, Hao Hu, Jinyou Li
  International Journal of Biological Macromolecules.2024; 278: 134835.     CrossRef
• Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factor
  Nam Hoon Kim, Juneyoung Lee, Suk Chon, Jae Myung Yu, In-Kyung Jeong, Soo Lim, Won Jun Kim, Keeho Song, Ho Chan Cho, Hea Min Yu, Kyoung-Ah Kim, Sang Soo Kim, Soon Hee Lee, Chong Hwa Kim, Soo Heon Kwak, Yong‐ho Lee, Choon Hee Chung, Sihoon Lee, Heung Yong J
  Endocrinology and Metabolism.2024; 39(5): 722.     CrossRef
• Safety and Efficacy of the Novel RNA Interference Therapies for Hypertriglyceridemia and Mixed Hyperlipidemia Management: A Systematic Review and Meta-analysis
  A.B.M. Kamrul-Hasan, Deep Dutta, Lakshmi Nagendra, Sunetra Mondal, Saptarshi Bhattacharya, Sanjay Kalra
  Endocrine Practice.2024; 30(11): 1103.     CrossRef
• Effects of Fatty Acid Metabolism on Heart Failure
  日娜 萨
  Advances in Clinical Medicine.2024; 14(09): 787.     CrossRef
• Revisiting PPAR agonists: novel perspectives in the treatment of primary biliary cholangitis
  Yiran Chen, Kunyu Zheng, Gahu Da, Xu Wang, Yi Wei, Guochun Wang, Fengchun Zhang, Li Wang
  Expert Opinion on Pharmacotherapy.2024; 25(13): 1825.     CrossRef
• Integrated review of cardiometabolic biomarkers and dietary nutrients
  Ravindra Verma, Prakash S Bisen, Mònica Bulló
  Journal of Food Bioactives.2024; : 44.     CrossRef
• Cardiovascular Diseases and Metabolic Medications in the Lebanese Population: A Post Hoc Analysis from a Nationwide Cross-Sectional Study
  Rony M. Zeenny, Rachel Abdo, Chadia Haddad, Aline Hajj, Rouba Karen Zeidan, Pascale Salameh, Jean Ferrieres
  Pharmacy.2024; 12(6): 171.     CrossRef
• Present and Future of Dyslipidaemia Treatment—A Review
  Iveta Merćep, Andro Vujević, Dominik Strikić, Ivana Radman, Ivan Pećin, Željko Reiner
  Journal of Clinical Medicine.2023; 12(18): 5839.     CrossRef
• VLDL receptor gene therapy for reducing atherogenic lipoproteins
  Ronald M. Krauss, Jonathan T. Lu, Joseph J. Higgins, Cathryn M. Clary, Ray Tabibiazar
  Molecular Metabolism.2023; 69: 101685.     CrossRef
• The emerging role of PPAR-alpha in breast cancer
  Zhiwen Qian, Lingyan Chen, Jiayu Liu, Ying Jiang, Yan Zhang
  Biomedicine & Pharmacotherapy.2023; 161: 114420.     CrossRef
• Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and disease
  Yujie Pu, Chak Kwong Cheng, Hongsong Zhang, Jiang‐Yun Luo, Li Wang, Brian Tomlinson, Yu Huang
  Medicinal Research Reviews.2023; 43(6): 2086.     CrossRef
• Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism
  DuoYao Cao, Zakir Khan, Xiaomo Li, Suguru Saito, Ellen A Bernstein, Aaron R Victor, Faizan Ahmed, Aoi O Hoshi, Luciana C Veiras, Tomohiro Shibata, Mingtian Che, Lei Cai, Michifumi Yamashita, Ryan E Temel, Jorge F Giani, Daniel J Luthringer, Ajit S Divakar
  Cardiovascular Research.2023; 119(9): 1825.     CrossRef
• Rapid flow synthesis of fenofibrate via scalable flash chemistry with in-line Li recovery
  Sanket A. Kawale, Dong-Chang Kang, Gwang-Noh Ahn, Amirreza Mottafegh, Ji-Ho Kang, Gi-Su Na, Dong-Pyo Kim
  Chemical Engineering Journal.2023; 477: 147033.     CrossRef
• Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome
  Marat V. Ezhov, Gregory P. Arutyunov
  Diseases.2023; 11(4): 140.     CrossRef
• Development of New Genome Editing Tools for the Treatment of Hyperlipidemia
  Giulio Preta
  Cells.2023; 12(20): 2466.     CrossRef
• Exploring the hypolipidemic effects of bergenin from Saxifraga melanocentra Franch: mechanistic insights and potential for hyperlipidemia treatment
  Li Zhang, Yingying Tong, Yan Fang, Jinjin Pei, Qilan Wang, Gang Li
  Lipids in Health and Disease.2023;[Epub]     CrossRef
• Obesity and Dyslipidemia
  Barbora Nussbaumerova, Hana Rosolova
  Current Atherosclerosis Reports.2023; 25(12): 947.     CrossRef
• Bibliometric analysis of residual cardiovascular risk: trends and frontiers
  Lin Wang, Sutong Wang, Chaoyuan Song, Yiding Yu, Yuehua Jiang, Yongcheng Wang, Xiao Li
  Journal of Health, Population and Nutrition.2023;[Epub]     CrossRef
• Hypertriglyceridemia in Apoa5–/– mice results from reduced amounts of lipoprotein lipase in the capillary lumen
  Ye Yang, Anne P. Beigneux, Wenxin Song, Le Phuong Nguyen, Hyesoo Jung, Yiping Tu, Thomas A. Weston, Caitlyn M. Tran, Katherine Xie, Rachel G. Yu, Anh P. Tran, Kazuya Miyashita, Katsuyuki Nakajima, Masami Murakami, Yan Q. Chen, Eugene Y. Zhen, Joonyoung R.
  Journal of Clinical Investigation.2023;[Epub]     CrossRef
• Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update
  Dipali Kale, Amol Fatangare, Prasad Phapale, Albert Sickmann
  Cells.2023; 12(24): 2796.     CrossRef
• Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia
  Gary F Lewis, Robert A Hegele
  The Lancet Diabetes & Endocrinology.2022; 10(2): 142.     CrossRef
• Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study
  Thomas Metzner, Deborah R. Leitner, Karin Mellitzer, Andrea Beck, Harald Sourij, Tatjana Stojakovic, Gernot Reishofer, Winfried März, Ulf Landmesser, Hubert Scharnagl, Hermann Toplak, Günther Silbernagel
  Biomedicines.2022; 10(1): 193.     CrossRef
• Is there a role of lipid-lowering therapies in the management of fatty liver disease?
  Ismini Tzanaki, Aris P Agouridis, Michael S Kostapanos
  World Journal of Hepatology.2022; 14(1): 119.     CrossRef
• Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?
  Ana Clara Aprotosoaie, Alexandru-Dan Costache, Irina-Iuliana Costache
  Pharmaceutics.2022; 14(4): 722.     CrossRef
• The Overlooked Transformation Mechanisms of VLCFAs: Peroxisomal β-Oxidation
  Qinyue Lu, Weicheng Zong, Mingyixing Zhang, Zhi Chen, Zhangping Yang
  Agriculture.2022; 12(7): 947.     CrossRef
• Current Trends of Big Data Research Using the Korean National Health Information Database
  Mee Kyoung Kim, Kyungdo Han, Seung-Hwan Lee
  Diabetes & Metabolism Journal.2022; 46(4): 552.     CrossRef
• New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
  Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi
  Diabetes & Metabolism Journal.2022; 46(4): 517.     CrossRef
• Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure
  Agata Jedrzejewska, Alicja Braczko, Ada Kawecka, Marcin Hellmann, Piotr Siondalski, Ewa Slominska, Barbara Kutryb-Zajac, Magdi H. Yacoub, Ryszard T. Smolenski
  International Journal of Molecular Sciences.2022; 23(17): 9886.     CrossRef
• Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
  Joon Ho Moon, Kyuho Kim, Sung Hee Choi
  Endocrinology and Metabolism.2022; 37(4): 575.     CrossRef
• Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
  Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
  Metabolism.2022; 137: 155327.     CrossRef
• Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
  Veronika Vyletelová, Mária Nováková, Ľudmila Pašková
  Pharmaceuticals.2022; 15(10): 1278.     CrossRef
• Cardiovascular Risk Profile and Lipid Management in the Population-Based Cohort Study LATINO: 20 Years of Real-World Data
  Cristina Gavina, Daniel Seabra Carvalho, Marisa Pardal, Marta Afonso-Silva, Diana Grangeia, Ricardo Jorge Dinis-Oliveira, Francisco Araújo, Tiago Taveira-Gomes
  Journal of Clinical Medicine.2022; 11(22): 6825.     CrossRef
• New and Emerging lipid-lowering Therapy
  James M Backes, Daniel E Hilleman
  Future Cardiology.2021; 17(8): 1407.     CrossRef
• Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
  Styliani Fragki, Hubert Dirven, Tony Fletcher, Bettina Grasl-Kraupp, Kristine Bjerve Gützkow, Ron Hoogenboom, Sander Kersten, Birgitte Lindeman, Jochem Louisse, Ad Peijnenburg, Aldert H. Piersma, Hans M. G. Princen, Maria Uhl, Joost Westerhout, Marco J. Z
  Critical Reviews in Toxicology.2021; 51(2): 141.     CrossRef
• A network pharmacology analysis on drug‐like compounds from Ganoderma lucidum for alleviation of atherosclerosis
  Ki Kwang Oh, Md. Adnan, Dong Ha Cho
  Journal of Food Biochemistry.2021;[Epub]     CrossRef
• Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV Study
  Myung Soo Park, Jong-Chan Youn, Eung Ju Kim, Ki Hoon Han, Sang Hak Lee, Sung Hea Kim, Byung Jin Kim, Sung Uk Kwon, Kyu-Hyung Ryu
  Clinical Therapeutics.2021; 43(10): 1735.     CrossRef
• Prevalence of and Factors Associated With the Prescription of Fibrates Among Patients Receiving Lipid-Lowering Drugs in Germany
  Louis Jacob, Roger-Axel Greiner, Mark Luedde, Karel Kostev
  Journal of Cardiovascular Pharmacology.2021; 78(6): 885.     CrossRef
• Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature
  Leili Rahimi, Mojtaba Malek, Faramarz Ismail-Beigi, Mohammad E. Khamseh
  Advances in Therapy.2020; 37(8): 3450.     CrossRef
• Treatment With Gemfibrozil Prevents the Progression of Chronic Kidney Disease in Obese Dahl Salt-Sensitive Rats
  Corbin A. Shields, Bibek Poudel, Kasi C. McPherson, Andrea K. Brown, Ubong S. Ekperikpe, Evan Browning, Lamari Sutton, Denise C. Cornelius, Jan M. Williams
  Frontiers in Physiology.2020;[Epub]     CrossRef
• Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes
  Amelia Charlton, Jessica Garzarella, Karin A. M. Jandeleit-Dahm, Jay C. Jha
  Biology.2020; 10(1): 18.     CrossRef

Since the mitochondrial pyruvate dehydrogenase complex (PDC) controls the rate of carbohydrate oxidation, impairment of PDC activity mediated by high-fat intake has been advocated as a causative factor for the skeletal muscle insulin resistance, metabolic syndrome, and the onset of type 2 diabetes (T2D). There are also situations where muscle insulin resistance can occur independently from high-fat dietary intake such as sepsis, inflammation, or drug administration though they all may share the same underlying mechanism, i.e., via activation of forkhead box family of transcription factors, and to a lower extent via peroxisome proliferator-activated receptors. The main feature of T2D is a chronic elevation in blood glucose levels. Chronic systemic hyperglycaemia is toxic and can lead to cellular dysfunction that may become irreversible over time due to deterioration of the pericyte cell's ability to provide vascular stability and control to endothelial proliferation. Therefore, it may not be surprising that T2D's complications are mainly macrovascular and microvascular related, i.e., neuropathy, retinopathy, nephropathy, coronary artery, and peripheral vascular diseases. However, life style intervention such as exercise, which is the most potent physiological activator of muscle PDC, along with pharmacological intervention such as administration of dichloroacetate or L-carnitine can prove to be viable strategies for treating muscle insulin resistance in obesity and T2D as they can potentially restore whole body glucose disposal.

Citations

Citations to this article as recorded by  

• Oxidative stress and metabolism meet epigenetic modulation in physical exercise
  José Luis García-Giménez, Irene Cánovas-Cervera, Federico V. Pallardó
  Free Radical Biology and Medicine.2024; 213: 123.     CrossRef
• The pyruvate dehydrogenase complex: Life’s essential, vulnerable and druggable energy homeostat
  Peter W. Stacpoole, Charles E. McCall
  Mitochondrion.2023; 70: 59.     CrossRef
• Regulating mitochondrial metabolism by targeting pyruvate dehydrogenase with dichloroacetate, a metabolic messenger
  Nick Schoenmann, Nicholas Tannenbaum, Ryan M. Hodgeman, Raghavan Pillai Raju
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2023; 1869(7): 166769.     CrossRef
• Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls
  Héctor F. Escobar-Morreale, María Ángeles Martínez-García, María Insenser, Nicolau Cañellas, Xavier Correig, Manuel Luque-Ramírez
  Biology of Sex Differences.2023;[Epub]     CrossRef
• Metabolomics and mitochondrial dysfunction in cardiometabolic disease
  Abhishek Shastry, Kimberly Dunham-Snary
  Life Sciences.2023; 333: 122137.     CrossRef
• Loss of metabolic flexibility as a result of overexpression of pyruvate dehydrogenase kinases in muscle, liver and the immune system: Therapeutic targets in metabolic diseases
  Jae‐Han Jeon, Themis Thoudam, Eun Jung Choi, Min‐Ji Kim, Robert A Harris, In‐Kyu Lee
  Journal of Diabetes Investigation.2021; 12(1): 21.     CrossRef
• Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy
  Saleha Anwar, Anas Shamsi, Taj Mohammad, Asimul Islam, Md. Imtaiyaz Hassan
  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2021; 1876(1): 188568.     CrossRef
• Effect of exercise training on skeletal muscle protein expression in relation to insulin sensitivity: Per‐protocol analysis of a randomized controlled trial (GO‐ACTIWE)
  Lea Bruhn, Rasmus Kjøbsted, Jonas Salling Quist, Anne Sofie Gram, Mads Rosenkilde, Kristine Færch, Jørgen F.P. Wojtaszewski, Bente Stallknecht, Martin Bæk Blond
  Physiological Reports.2021;[Epub]     CrossRef
• The Mechanism behind Influenza Virus Cytokine Storm
  Yinuo Gu, Xu Zuo, Siyu Zhang, Zhuoer Ouyang, Shengyu Jiang, Fang Wang, Guoqiang Wang
  Viruses.2021; 13(7): 1362.     CrossRef
• Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α
  Nives Škorja Milić, Klemen Dolinar, Katarina Miš, Urška Matkovič, Maruša Bizjak, Mojca Pavlin, Matej Podbregar, Sergej Pirkmajer
  International Journal of Molecular Sciences.2021; 22(16): 8610.     CrossRef
• The Regulatory Roles of PPARs in Skeletal Muscle Fuel Metabolism and Inflammation: Impact of PPAR Agonism on Muscle in Chronic Disease, Contraction and Sepsis
  Hannah Crossland, Dumitru Constantin-Teodosiu, Paul L. Greenhaff
  International Journal of Molecular Sciences.2021; 22(18): 9775.     CrossRef
• PPARα, δ and FOXO1 Gene Silencing Overturns Palmitate-Induced Inhibition of Pyruvate Oxidation Differentially in C2C12 Myotubes
  Hung-Che Chien, Despina Constantin, Paul L. Greenhaff, Dumitru Constantin-Teodosiu
  Biology.2021; 10(11): 1098.     CrossRef
• Molecular Mechanisms of Muscle Fatigue
  Dumitru Constantin-Teodosiu, Despina Constantin
  International Journal of Molecular Sciences.2021; 22(21): 11587.     CrossRef
• Coronavirus Disease-19 (COVID-19) and Modern Lifestyle Diseases
  Pallav Sengupta, Sulagna Dutta
  Biomedical and Pharmacology Journal.2021; 14(4): 2245.     CrossRef
• A single bout of resistance exercise improves postprandial lipid metabolism in overweight/obese men with prediabetes
  Adam J. Bittel, Daniel C. Bittel, Bettina Mittendorfer, Bruce W. Patterson, Adewole L. Okunade, Jun Yoshino, Lane C. Porter, Nada A. Abumrad, Dominic N. Reeds, W. Todd Cade
  Diabetologia.2020; 63(3): 611.     CrossRef
• An integrative approach to the regulation of mitochondrial respiration during exercise: Focus on high-intensity exercise
  Jose A.L. Calbet, Saúl Martín-Rodríguez, Marcos Martin-Rincon, David Morales-Alamo
  Redox Biology.2020; 35: 101478.     CrossRef
• PPARδ and FOXO1 Mediate Palmitate-Induced Inhibition of Muscle Pyruvate Dehydrogenase Complex and CHO Oxidation, Events Reversed by Electrical Pulse Stimulation
  Hung-Che Chien, Paul L. Greenhaff, Dumitru Constantin-Teodosiu
  International Journal of Molecular Sciences.2020; 21(16): 5942.     CrossRef
• Cancer cachexia has many symptoms but only one cause: anoxia
  Tomas Koltai
  F1000Research.2020; 9: 250.     CrossRef
• Structural basis for the inhibition of PDK2 by novel ATP- and lipoyl-binding site targeting compounds
  Jihoon Kang, Haushabhau S. Pagire, Donguk Kang, Yo Han Song, In Kyu Lee, Kang Taek Lee, Chin-Ju Park, Jin Hee Ahn, Jungwook Kim
  Biochemical and Biophysical Research Communications.2020; 527(3): 778.     CrossRef
• Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic
  Livio Luzi, Maria Grazia Radaelli
  Acta Diabetologica.2020; 57(6): 759.     CrossRef
• Changes in gene expression of lactate carriers (MCT1 and CD147) in cardiac muscle of diabetic male rats: the effect of dichloroacetate and endurance training
  H. Rezaeinasab, A. Habibi, M. Nikbakht, M. Rashno, S. Shakerian
  The Ukrainian Biochemical Journal.2020; 92(5): 111.     CrossRef
• Mitochondrial Uncoupling Coordinated With PDH Activation Safely Ameliorates Hyperglycemia via Promoting Glucose Oxidation
  Haowen Jiang, Jia Jin, Yanan Duan, Zhifu Xie, Yufeng Li, Anhui Gao, Min Gu, Xinwen Zhang, Chang Peng, Chunmei Xia, Tiancheng Dong, Hui Li, Lifang Yu, Jie Tang, Fan Yang, Jingya Li, Jia Li
  Diabetes.2019; 68(12): 2197.     CrossRef
• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Induced by Repeated Forced Swimming in Mice
  Takuya Ohba, Shinichi Domoto, Miyu Tanaka, Shinsuke Nakamura, Masamitsu Shimazawa, Hideaki Hara
  Biological and Pharmaceutical Bulletin.2019; 42(7): 1140.     CrossRef
• The Beta Cell in Type 2 Diabetes
  Ashley A. Christensen, Maureen Gannon
  Current Diabetes Reports.2019;[Epub]     CrossRef
• Reduced expression of Twist 1 is protective against insulin resistance of adipocytes and involves mitochondrial dysfunction
  Sumei Lu, Hong Wang, Rui Ren, Xiaohong Shi, Yanmei Zhang, Wanshan Ma
  Scientific Reports.2018;[Epub]     CrossRef
• PDK4 Deficiency Suppresses Hepatic Glucagon Signaling by Decreasing cAMP Levels
  Bo-Yoon Park, Jae-Han Jeon, Younghoon Go, Hye Jin Ham, Jeong-Eun Kim, Eun Kyung Yoo, Woong Hee Kwon, Nam-Ho Jeoung, Yong Hyun Jeon, Seung-Hoi Koo, Byung-Gyu Kim, Ling He, Keun-Gyu Park, Robert A. Harris, In-Kyu Lee
  Diabetes.2018; 67(10): 2054.     CrossRef
• Differences in Muscle Metabolism Between Triathletes and Normally Active Volunteers Investigated Using Multinuclear Magnetic Resonance Spectroscopy at 7T
  Radka Klepochová, Ladislav Valkovič, Thomas Hochwartner, Christoph Triska, Norbert Bachl, Harald Tschan, Siegfried Trattnig, Michael Krebs, Martin Krššák
  Frontiers in Physiology.2018;[Epub]     CrossRef
• Defining the contribution of skeletal muscle pyruvate dehydrogenase α1 to exercise performance and insulin action
  Kristoffer Svensson, Jessica R. Dent, Shahriar Tahvilian, Vitor F. Martins, Abha Sathe, Julien Ochala, Mulchand S. Patel, Simon Schenk
  American Journal of Physiology-Endocrinology and Metabolism.2018; 315(5): E1034.     CrossRef
• Early-onset and classical forms of type 2 diabetes show impaired expression of genes involved in muscle branched-chain amino acids metabolism
  María Isabel Hernández-Alvarez, Angels Díaz-Ramos, María Berdasco, Jeff Cobb, Evarist Planet, Diane Cooper, Agnieszka Pazderska, Krzystof Wanic, Declan O’Hanlon, Antonio Gomez, Laura R. de la Ballina, Manel Esteller, Manuel Palacin, Donal J. O’Gorman, Joh
  Scientific Reports.2017;[Epub]     CrossRef
• Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer
  Peter W Stacpoole
  JNCI: Journal of the National Cancer Institute.2017;[Epub]     CrossRef
• Hyperpalatable Diet and Physical Exercise Modulate the Expression of the Glial Monocarboxylate Transporters MCT1 and 4
  Luis V. Portela, Andressa W. Brochier, Clarissa B. Haas, Afonso Kopczynski de Carvalho, Jussania A. Gnoato, Eduardo R. Zimmer, Eduardo Kalinine, Luc Pellerin, Alexandre P. Muller
  Molecular Neurobiology.2017; 54(8): 5807.     CrossRef
• Mitochondrial targeting by dichloroacetate improves outcome following hemorrhagic shock
  Kumar Subramani, Sumin Lu, Marie Warren, Xiaogang Chu, Haroldo A. Toque, R. William Caldwell, Michael P. Diamond, Raghavan Raju
  Scientific Reports.2017;[Epub]     CrossRef
• The effect of age and unilateral leg immobilization for 2 weeks on substrate utilization during moderate‐intensity exercise in human skeletal muscle
  A. Vigelsø, M. Gram, R. Dybboe, A. B. Kuhlman, C. Prats, P. L. Greenhaff, D. Constantin‐Teodosiu, J. B. Birk, J. F. P. Wojtaszewski, F. Dela, J. W. Helge
  The Journal of Physiology.2016; 594(8): 2339.     CrossRef
• Global Kinetic Analysis of Mammalian E3 Reveals pH-dependent NAD+/NADH Regulation, Physiological Kinetic Reversibility, and Catalytic Optimum
  Michael A. Moxley, Daniel A. Beard, Jason N. Bazil
  Journal of Biological Chemistry.2016; 291(6): 2712.     CrossRef
• Pyruvate dehydrogenase kinase regulates hepatitis C virus replication
  Gwon-Soo Jung, Jae-Han Jeon, Yeon-Kyung Choi, Se Young Jang, Soo Young Park, Sung-Woo Kim, Jun-Kyu Byun, Mi-Kyung Kim, Sungwoo Lee, Eui-Cheol Shin, In-Kyu Lee, Yu Na Kang, Keun-Gyu Park
  Scientific Reports.2016;[Epub]     CrossRef
• Altered heart proteome in fructose-fed Fisher 344 rats exposed to bisphenol A
  S.A. Ljunggren, M. Iggland, M. Rönn, L. Lind, P.M. Lind, H. Karlsson
  Toxicology.2016; 347-349: 6.     CrossRef
• Unacylated ghrelin restores insulin and autophagic signaling in skeletal muscle of diabetic mice
  Bjorn T. Tam, Xiao M. Pei, Benjamin Y. Yung, Shea P. Yip, Lawrence W. Chan, Cesar S. Wong, Parco M. Siu
  Pflügers Archiv - European Journal of Physiology.2015; 467(12): 2555.     CrossRef
• Sex-related differences in the effects of high-fat diets on DHEA-treated rats
  Ana Lúcia Cecconello, Marcia Trapp, Ana Lúcia Hoefel, Cláudia Vieira Marques, Bruno Dutra Arbo, Gabriela Osterkamp, Luiz Carlos Rios Kucharski, Maria Flávia Marques Ribeiro
  Endocrine.2015; 48(3): 985.     CrossRef
• Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle
  Sergio Arrabal, Miguel Angel Lucena, Miren Josune Canduela, Almudena Ramos-Uriarte, Patricia Rivera, Antonia Serrano, Francisco Javier Pavón, Juan Decara, Antonio Vargas, Elena Baixeras, Mercedes Martín-Rufián, Javier Márquez, Pedro Fernández-Llébrez, Bau
  PLOS ONE.2015; 10(12): e0145244.     CrossRef
• A glance at … exercise and glucose uptake
  Michael J. Glade, Kyl Smith
  Nutrition.2015; 31(6): 893.     CrossRef
• Perpetual muscle PDH activation in PDH kinase knockout mice protects against high-fat feeding–induced muscle insulin resistance
  Dumitru Constantin-Teodosiu, Francis B. Stephens, Paul L. Greenhaff
  Proceedings of the National Academy of Sciences.2015;[Epub]     CrossRef
• Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial Content
  Craig A. Goodman, Derk Pol, Evelyn Zacharewicz, Robert S. Lee-Young, Rod J. Snow, Aaron P. Russell, Glenn K. McConell, Ashok Kumar
  PLOS ONE.2015; 10(5): e0128398.     CrossRef
• 13C metabolic flux analysis shows that resistin impairs the metabolic response to insulin in L6E9 myotubes
  Shirley Guzmán, Silvia Marin, Anibal Miranda, Vitaly A Selivanov, Josep J Centelles, Romain Harmancey, Fatima Smih, Annie Turkieh, Yves Durocher, Antonio Zorzano, Philippe Rouet, Marta Cascante
  BMC Systems Biology.2014;[Epub]     CrossRef
• Translational Research: From Biological Discovery to Public Benefit (or Not)
  Michael R. Emmert-Buck
  Advances in Biology.2014; 2014: 1.     CrossRef
• Diabetic Worker with History of Falls: A Case Study
  Ann R. Lurati
  Workplace Health & Safety.2014; 62(5): 175.     CrossRef
• Diabetic Worker With History of Falls: A Case Study
  Ann R. Lurati
  Workplace Health & Safety.2014; 62(5): 175.     CrossRef
• Mitochondrial Pyruvate Carrier 2 Hypomorphism in Mice Leads to Defects in Glucose-Stimulated Insulin Secretion
  Patrick A. Vigueira, Kyle S. McCommis, George G. Schweitzer, Maria S. Remedi, Kari T. Chambers, Xiaorong Fu, William G. McDonald, Serena L. Cole, Jerry R. Colca, Rolf F. Kletzien, Shawn C. Burgess, Brian N. Finck
  Cell Reports.2014; 7(6): 2042.     CrossRef

Citations

Citations to this article as recorded by  

• Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation
  Bodo Haas, Moritz David Sebastian Hass, Alexander Voltz, Matthias Vogel, Julia Walther, Arijit Biswas, Daniela Hass, Alexander Pfeifer
  Molecular Metabolism.2024; 85: 101956.     CrossRef
• Chitosan-Encapsulated Nano-selenium Targeting TCF7L2, PPARγ, and CAPN10 Genes in Diabetic Rats
  Omayma A. R. Abozaid, Sawsan M. El-Sonbaty, Neama M. A. Hamam, Moustafa A. Farrag, Ahmad S. Kodous
  Biological Trace Element Research.2023; 201(1): 306.     CrossRef
• Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitus
  Ayesha Fauzi, Ewen Se Thoe, Tang Yin Quan, Adeline Chia Yoke Yin
  Journal of Diabetes and its Complications.2023; 37(11): 108629.     CrossRef
• Novel Sulfonanilide Inhibitors of SHIP2 Enhance Glucose Uptake into Cultured Myotubes
  Mika E. A. Berg, Jette-Britt Naams, Laura C. Hautala, Tuomas A. Tolvanen, Jari P. Ahonen, Sanna Lehtonen, Kristiina Wähälä
  ACS Omega.2020; 5(3): 1430.     CrossRef
• Diabetic Theory in Anti-Alzheimer’s Drug Research and Development - Part 1: Therapeutic Potential of Antidiabetic Agents
  Agnieszka Jankowska, Anna Wesołowska, Maciej Pawłowski, Grażyna Chłoń-Rzepa
  Current Medicinal Chemistry.2020; 27(39): 6658.     CrossRef
• Moringa concanensis Nimmo extracts ameliorates hyperglycemia-mediated oxidative stress and upregulates PPARγ and GLUT4 gene expression in liver and pancreas of streptozotocin-nicotinamide induced diabetic rats
  Brindha Banu Balakrishnan, Kalaivani Krishnasamy, Vijayakumar Mayakrishnan, Arokiyaraj Selvaraj
  Biomedicine & Pharmacotherapy.2019; 112: 108688.     CrossRef
• PPARγ Agonistic Activity of Sulphonylureas
  Debjani Banerjee, Harnovdeep Singh Bharaj, Moulinath Banerjee
  Endocrine, Metabolic & Immune Disorders - Drug Targets.2019; 19(4): 467.     CrossRef
• Glimepiride treatment in a patient with type A insulin resistance syndrome due to a novel heterozygous missense mutation in the insulin receptor gene
  Zhimin Huang, Juan Liu, Kaka Ng, Xuesi Wan, Lijuan Xu, Xiaoying He, Zhihong Liao, Yanbing Li
  Journal of Diabetes Investigation.2018; 9(5): 1075.     CrossRef
• Arsenic, Cadmium, and Lead Like Troglitazone Trigger PPARγ-Dependent Poly (ADP-Ribose) Polymerase Expression and Subsequent Apoptosis in Rat Brain Astrocytes
  Rajesh Kushwaha, Juhi Mishra, Sachin Tripathi, Puneet Khare, Sanghamitra Bandyopadhyay
  Molecular Neurobiology.2018; 55(3): 2125.     CrossRef
• Docosahexaenoic acid up‐regulates both PI3K/AKT‐dependent FABP7–PPARγ interaction and MKP3 that enhance GFAP in developing rat brain astrocytes
  Sachin Tripathi, Rajesh Kushwaha, Juhi Mishra, Manoj Kumar Gupta, Harish Kumar, Somali Sanyal, Dhirendra Singh, Sabyasachi Sanyal, Amogh Anant Sahasrabuddhe, Mohan Kamthan, Mohana Krishna Reddy Mudiam, Sanghamitra Bandyopadhyay
  Journal of Neurochemistry.2017; 140(1): 96.     CrossRef
• Antiglycation and cell protective actions of metformin and glipizide in erythrocytes and monocytes
  Krishna Adeshara, Rashmi Tupe
  Molecular Biology Reports.2016; 43(3): 195.     CrossRef
• The therapeutic journey of pyridazinone
  Wasim Akhtar, M. Shaquiquzzaman, Mymoona Akhter, Garima Verma, Mohemmed Faraz Khan, M. Mumtaz Alam
  European Journal of Medicinal Chemistry.2016; 123: 256.     CrossRef
• Antidiabetic effect of novel benzenesulfonylureas as PPAR-γ agonists and their anticancer effect
  Chetna Kharbanda, Mohammad Sarwar Alam, Hinna Hamid, Kalim Javed, Abhijeet Dhulap, Sameena Bano, Yakub Ali
  Bioorganic & Medicinal Chemistry Letters.2015; 25(20): 4601.     CrossRef
• Method Development and Validation of Amlodipine, Gliquidone and Pioglitazone: Application in the Analysis of Human Serum
  Agha Zeeshan Mirza, M. Saeed Arayne, Najma Sultana
  Analytical Chemistry Letters.2014; 4(5-6): 302.     CrossRef
• Gliquidone decreases urinary protein by promoting tubular reabsorption in diabetic Goto-Kakizaki rats
  Jian-Ting Ke, Mi Li, Shi-Qing Xu, Wen-Jian Zhang, Yong-Wei Jiang, Lan-yun Cheng, Li Chen, Jin-Ning Lou, Wei Wu
  Journal of Endocrinology.2014; 220(2): 129.     CrossRef
• Extension of Drosophila lifespan by cinnamon through a sex-specific dependence on the insulin receptor substrate chico
  Samuel E. Schriner, Steven Kuramada, Terry E. Lopez, Stephanie Truong, Andrew Pham, Mahtab Jafari
  Experimental Gerontology.2014; 60: 220.     CrossRef
• Crif1 Deficiency Reduces Adipose OXPHOS Capacity and Triggers Inflammation and Insulin Resistance in Mice
  Min Jeong Ryu, Soung Jung Kim, Yong Kyung Kim, Min Jeong Choi, Surendar Tadi, Min Hee Lee, Seong Eun Lee, Hyo Kyun Chung, Saet Byel Jung, Hyun-Jin Kim, Young Suk Jo, Koon Soon Kim, Sang-Hee Lee, Jin Man Kim, Gi Ryang Kweon, Ki Cheol Park, Jung Uee Lee, Yo
  PLoS Genetics.2013; 9(3): e1003356.     CrossRef
• Glimepiride attenuates Aβ production via suppressing BACE1 activity in cortical neurons
  Feiyang Liu, Yijin Wang, Ming Yan, Luyong Zhang, Tao Pang, Hong Liao
  Neuroscience Letters.2013; 557: 90.     CrossRef
• Pharmacologic agents for type 2 diabetes therapy and regulation of adipogenesis
  A. Cignarelli, F. Giorgino, R. Vettor
  Archives of Physiology and Biochemistry.2013; 119(4): 139.     CrossRef
• Labisia pumilaUpregulates Peroxisome Proliferator-Activated Receptor Gamma Expression in Rat Adipose Tissues and 3T3-L1 Adipocytes
  Fazliana Mansor, Harvest F. Gu, Claes-Göran Östenson, Louise Mannerås-Holm, Elisabet Stener-Victorin, Wan Nazaimoon Wan Mohamud
  Advances in Pharmacological Sciences.2013; 2013: 1.     CrossRef
• Protocol for effective differentiation of 3T3-L1 cells to adipocytes
  Katja Zebisch, Valerie Voigt, Martin Wabitsch, Matthias Brandsch
  Analytical Biochemistry.2012; 425(1): 88.     CrossRef